Aurora Investment Counsel United Therapeutics Corp Transaction History

Aurora Investment Counsel

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 21, 2019	SELL	$101.4 - $128.73 $35,490 - $45,055	-350 Reduced 3.48%	9,704 $1.06 Million
Q3 2018 Oct 09, 2018	SELL	$113.81 - $129.46 $13,884 - $15,794	-122 Reduced 1.2%	10,054 $1.29 Million
Q2 2018 Jul 25, 2018	SELL	$101.14 - $118.31 $3,539 - $4,140	-35 Reduced 0.34%	10,176 $1.15 Million
Q1 2018 Apr 09, 2018	SELL	$107.21 - $151.94 $38,595 - $54,698	-360 Reduced 3.41%	10,211 $1.15 Million
Q4 2017 Jan 04, 2018	BUY	$118.58 - $151.28 $1.25 Million - $1.6 Million	10,571	10,571 $1.56 Million

731

40.8M

123K

104K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $13B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Aurora Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Aurora Investment Counsel with notifications on news.